Tag: FDA

Addressing Suppository Deformation Issues During Bulk Hold: A Comprehensive CAPA Approach In the realm of pharmaceutical manufacturing, maintaining the integrity of product forms is vital. One such challenge arises with…

Addressing Pet Failures in Accelerated Stability: An Investigation Guide for Pharma Professionals Pet failures during accelerated stability testing represent a significant challenge within pharmaceutical manufacturing, particularly for dosage forms such…

Addressing Melting Point Failures in Suppository Manufacturing: A Comprehensive CAPA Guide In the pharmaceutical manufacturing landscape, maintaining product quality is paramount, particularly when it comes to dosage forms like suppositories.…

Addressing Pet Failure from Temperature Excursions: Effective CAPA for Auditors In the pharmaceutical manufacturing sector, deviations such as Pet Failure after temperature excursion can pose significant challenges in product quality…

Investigating Pet Failure Following an Excipient Change in Pharmaceutical Manufacturing Pharmaceutical manufacturers often face challenges when introducing new excipients in formulation processes, particularly with sensitive dosage forms such as rectal…

Understanding the Investigation Process for Microbial Limits Failure in Suppository Manufacturing Microbial limits failure during the manufacturing of suppositories can lead to significant regulatory scrutiny and potential product recalls. Such…

Assessing Microbial Limits Failure during Vaginal Gel Production: Effective Process Controls In pharmaceutical manufacturing, ensuring product quality and compliance with microbial limits is paramount. A deviation related to microbial limits…